Condition: IBD and Renal Involement · Chronic Kidney Disease · Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) · Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
The NEPHRO-IBD study is a multicenter prospective observational study designed to evaluate the prevalence of renal dysfunction and renal complications in adult patients with inflammatory bowel disease (IBD) compared with individuals from the general population. Although extraintestinal manifestations are common in IBD, renal involvement remains relatively underrecognized and insufficiently studied. The study will recruit approximately 6,000 participants, including 3,000 patients with confirmed IBD (Crohn's disease or ulcerative colitis) and 3,000 individuals without IBD serving as a control group. Participants will undergo routine clinical assessment, including laboratory tests, urinalysis with measurement of the albumin-to-creatinine ratio (ACR), and imaging evaluation of the kidneys and urinary tract. Disease activity in patients with IBD will be assessed using validated clinical indices. The study will also evaluate the relationship between renal dysfunction and disease activity, medications used in IBD treatment, and comorbidities. The results of this study are expected to improve the understanding of renal complications in patients with IBD and support earlier identification and management of kidney disease in this population.
This description comes directly from the study's public registry record.
Krzysztof Jaroń, MD, MPharm · +48 477 22 12 40 · krzysztof.jaron@pimmswia.gov.pl
Konrad Lewandowski, Associate/Assistant Professor · + 48 477 22 12 40 · konrad.lewandowski@pimmswia.gov.pl
Always discuss trial participation with your own doctor first.
| National Medical Institute of the Ministry of the Interior and Administration, Clinic of Gastroenterology and Internal Diseases | Warsaw, Warszawa, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07593352